Intuitive Surgical, Inc. (NASDAQ:ISRG) Stake Reduced by FFT Wealth Management LLC

FFT Wealth Management LLC decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 39.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 636 shares of the medical equipment provider’s stock after selling 422 shares during the period. FFT Wealth Management LLC’s holdings in Intuitive Surgical were worth $332,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Berbice Capital Management LLC bought a new stake in Intuitive Surgical during the fourth quarter worth approximately $26,000. BankPlus Trust Department acquired a new stake in shares of Intuitive Surgical during the 4th quarter valued at $28,000. MidAtlantic Capital Management Inc. bought a new stake in shares of Intuitive Surgical during the 3rd quarter worth $33,000. Decker Retirement Planning Inc. acquired a new position in shares of Intuitive Surgical in the 4th quarter worth $36,000. Finally, Sierra Ocean LLC acquired a new stake in shares of Intuitive Surgical during the fourth quarter worth $40,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling

In related news, EVP Myriam Curet sold 408 shares of the business’s stock in a transaction that occurred on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the sale, the executive vice president now directly owns 353 shares in the company, valued at approximately $208,181.75. The trade was a 53.61 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Jamie Samath sold 94 shares of the stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the transaction, the chief financial officer now owns 2,630 shares in the company, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 6,240 shares of company stock worth $3,529,040. Corporate insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Down 2.9 %

ISRG stock opened at $573.74 on Wednesday. The company has a market capitalization of $204.35 billion, a price-to-earnings ratio of 89.51, a P/E/G ratio of 5.85 and a beta of 1.39. The firm has a 50 day moving average of $567.01 and a two-hundred day moving average of $527.27. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the company. Piper Sandler reissued an “overweight” rating and issued a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Leerink Partners lifted their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $522.00 to $650.00 in a report on Monday, December 2nd. Stifel Nicolaus raised their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, December 5th. Finally, Raymond James boosted their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.